Huffman v. SmithKline Beecham Clinical Laboratories, Inc.

111 F. Supp. 2d 921, 2000 U.S. Dist. LEXIS 12008, 2000 WL 1177435
CourtDistrict Court, N.D. Ohio
DecidedJune 20, 2000
Docket3:99CV7138
StatusPublished
Cited by1 cases

This text of 111 F. Supp. 2d 921 (Huffman v. SmithKline Beecham Clinical Laboratories, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Huffman v. SmithKline Beecham Clinical Laboratories, Inc., 111 F. Supp. 2d 921, 2000 U.S. Dist. LEXIS 12008, 2000 WL 1177435 (N.D. Ohio 2000).

Opinion

ORDER

CARR, District Judge.

This is a diversity jurisdiction case in which plaintiff alleges that defendants negligently diminished her husband’s chances of surviving colon cancer by failing properly to notify him of the severity of his blood test results taken as part of his employer’s “wellness program.” Pending are Defendant SmithKline Beecham Clinical Laboratories, Inc.’s (SmithKline Beecham) motion for summary judgment, (Doc. 51), and Defendant Whirlpool Corporation’s (Whirlpool) motion for summary judgment. (Doc. 18). For the following reasons, defendants’ motions for summary judgment shall be denied.

BACKGROUND

Plaintiff is the widow of Dennis Huffman. Mr. Huffman worked for Whirlpool in Findlay, Ohio from 1972 until the time of his death in October 1998.

Whirlpool maintains a health center at its production plant in Findlay, Ohio. For each of the three plant shifts, Whirlpool staffs a nurse at the health center. In addition, Whirlpool employs an on-site doctor one hour per day, four days a week.

As a benefit to its employees, Whirlpool also conducts a “wellness program,” as part of which employees and their spouses are offered a free, annual mini-physical examination. The mini-physical includes, among other things, an analysis of a sample of the participant’s blood.

On January 14, 1998, Mr. Huffman had his annual mini-physical examination. His blood sample was sent to SmithKline Beec-ham for analysis.

About three weeks later, Mr. Huffman received in the mail a copy of his blood test results and a “Personal Wellness Report.” His blood profile indicated that Mr. Huffman’s hemoglobin level was abnormally low, and that further examination should be undertaken. The materials sent to Mr. Huffman, however, contained no explanation of the significance of the low hemoglobin reading.

About a week to ten days after receiving the report, Mr. Huffman asked a nurse at Whirlpool about the meaning of a low hemoglobin level. The nurse told Mr. Huffman that it might mean that he was anemic, and that he should see his doctor. She also asked Mr. Huffman to bring the blood profile to the health center.

Aside from purchasing iron tablets, Mr. Huffman did nothing further about the blood report until March 18, 1998, when Mr. Huffman’s wife told their family physician, Dr. Kose, about his blood test results. Dr. Kose informed Mrs. Huffman that her husband should come in immediately to have his blood work redone. Within two days Mr. Huffman saw Dr. Kose, who took another blood sample that confirmed Mr. Huffman’s low hemoglobin level.

On March 25, 1998, Mr. Huffman had a colonoscopy, which indicated that he had colon cancer. The following day, Mr. *924 Huffman underwent a right eolonectomy. During the eolonectomy, the surgeon, Dr. Echavarre, examined Mr. Huffman’s liver, visually and by palpitation, and concluded that the cancer had not spread to his liver. But because the cancer had spread to five lymph nodes, Mr. Huffman was diagnosed with Stage C colon cancer.

Mr. Huffman was treated post-surgieally for his cancer. On April 14, 1998, Mr. Huffman was re-examined and the cancer was found to have spread to his liver. As a result, he was diagnosed with Stage D colon cancer, which is not curable. Mr. Huffman died on October 1,1998.

Dr. Sharon Cole, an oncologist, was one of Mr. Huffman’s treating physicians. She has testified that colon cancer is a progressive disease, and that Mr. Huffman’s cancer was the most aggressive cancer that she ever has treated. Dr. Cole also testified that the further the disease progresses, the less treatable it becomes. In her view, had Mr. Huffman’s condition been diagnosed when he first was informed of his low hemoglobin level, his chances of survival would have been increased.

Dr. Cole also testified that, in her opinion, Mr. Huffman had Stage C cancer (which is treatable), on March 26, 1998, rather than Stage D cancer (as first confirmed on April 15, 1998, and which is not treatable). Her opinion is based solely on Dr. Echavarre’s examination and post-surgical conclusion that the cancer had not spread into Mr. Huffman’s liver. Dr. Cole did not perform a CT scan on Mr. Huffman at the time he was diagnosed with Stage C cancer.

Plaintiff filed this action against Whirlpool and SmithKline Beecham alleging that they were negligent in interpreting, evaluating and providing blood test results to plaintiffs deceased husband, Mr. Huffman. As a result of defendants’ alleged negligence, plaintiff claims that her husband’s chances of surviving colon cancer were diminished.

Whirlpool argues that it is entitled to summary judgment because 1) it is immune from liability under the Ohio Constitution and Ohio Workers’ Compensation Law, 2) it is immune from liability under the fellow-servant rule, and 3) reasonable minds could not conclude that it acted negligently.

In addition, Whirlpool and SmithKline Beecham both move for summary judgment on the ground that plaintiff cannot prove causation. In particular, defendants argue that plaintiffs sole causation expert, Dr. Sharon Cole, should be excluded because her testimony cannot satisfy the admissibility criteria established under Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993), and Roberts v. Ohio Permanente Medical Group, Inc., 76 Ohio St.3d 483, 668 N.E.2d 480 (1996).

STANDARD OF REVIEW

Summary judgment must be entered “against a party who fails to make a showing sufficient to establish the existence of an element essential to that party’s case, and on which that party will bear the burden of proof at trial.” Celotex Corp. v. Catrett, 477 U.S. 317, 322, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986). The moving party always bears the initial responsibility of informing the district court of the basis for its motion, and identifying those portions of the record which demonstrate the absence of a genuine issue of material fact. Id. at 323, 106 S.Ct. 2548. The burden then shifts to the nonmoving party who “must set forth specific facts showing that there is a genuine issue for trial.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 250, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986) (quoting Fed.R.Civ.P. 56(e)).

Once the burden of production shifts, the party opposing summary judgment cannot rest on its pleadings or merely reassert its previous allegations. It is insufficient “simply [to] show that there is some metaphysical doubt as to the material facts.” Matsushita Elec. Indus. Co. v. *925 Zenith Radio Corp., 475 U.S. 574, 586, 106 S.Ct. 1348, 89 L.Ed.2d 538 (1986).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Saunders v. Holzer Hospital Foundation
891 N.E.2d 1202 (Ohio Court of Appeals, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
111 F. Supp. 2d 921, 2000 U.S. Dist. LEXIS 12008, 2000 WL 1177435, Counsel Stack Legal Research, https://law.counselstack.com/opinion/huffman-v-smithkline-beecham-clinical-laboratories-inc-ohnd-2000.